Literature DB >> 2782359

Ultrastructural aspects of preeclampsia. I. Placental bed and uterine boundary vessels.

D R Shanklin1, B M Sibai.   

Abstract

Biopsy specimens were obtained under direct vision at the time of cesarean section from 42 patients (33 preeclamptic and nine normotensive patients) and from three hysterectomies (all in normotensive patients). Mean gestational age was 32.8 +/- 0.9 week (range, 26 to 40 weeks) in women with preeclampsia and 36.1 +/- 1.1 weeks in normotensive women (range, 32 to 41 weeks). Tissues were obtained from the central placental bed and from nonplacental sites. Specimens were examined histologically and by electron microscopy. Ultrastructural changes in small vessels, primarily venules, were compared with preeclamptic blood pressure. Extensive ultrastructural endothelial injury was found consistently in both site and nonsite areas in all of the specimens from women with preeclampsia but not in normotensive women (p less than 0.0001). There was no apparent correlation between the type or degree of endothelial damage and maternal hypertension. The same types and relative severity of specific vascular injury were present in both placental and nonplacental sites. Endothelial and derivative vascular injury occurs more or less uniformly in the uterus in preeclampsia, especially along the boundary zone between maternal and fetal tissues.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2782359     DOI: 10.1016/0002-9378(89)90392-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

1.  Frequency and clinical significance of placental histological lesions in an unselected population at or near term.

Authors:  Sangeeta Pathak; Christoph C Lees; Gerald Hackett; Flora Jessop; Neil J Sebire
Journal:  Virchows Arch       Date:  2011-10-27       Impact factor: 4.064

2.  How useful is uterine artery Doppler ultrasonography in predicting pre-eclampsia and intrauterine growth restriction?

Authors:  Lynne McLeod
Journal:  CMAJ       Date:  2008-03-11       Impact factor: 8.262

3.  Primary antiphospholipid syndrome presenting as HELLP syndrome: a clinical pathology conference held by the Division of Rheumatology at Hospital for Special Surgery.

Authors:  Diane George; Lisa Vasanth; Doruk Erkan; Anne Bass; Jane Salmon; Michael D Lockshin
Journal:  HSS J       Date:  2007-04-26

Review 4.  Establishment of the Human Uteroplacental Circulation: A Historical Perspective.

Authors:  Kenna Degner; Ronald R Magness; Dinesh M Shah
Journal:  Reprod Sci       Date:  2016-10-12       Impact factor: 3.060

Review 5.  Complement in human reproduction: activation and control.

Authors:  I A Rooney; T J Oglesby; J P Atkinson
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

6.  Association between Angiotensinogen M235T Polymorphism and Preeclampsia in Iranian Pregnant Women.

Authors:  Raha Afshariani; Jamshid Roozbeh; Maryam Sharifian; Mahbobeh Ghaedi; Alamtaj Samsami Dehaghani; Abbas Ghaderi
Journal:  J Family Reprod Health       Date:  2014-12

7.  Aspirin and preeclampsia prevention in patients with abnormal uterine artery blood flow.

Authors:  Hamidreza Talari; Elahe Mesdaghinia; Masoumeh Abedzadeh Kalahroudi
Journal:  Iran Red Crescent Med J       Date:  2014-08-05       Impact factor: 0.611

8.  Hypothyroidism and diabetes mellitus - a risky dual gestational endocrinopathy.

Authors:  Dan Tirosh; Neta Benshalom-Tirosh; Lena Novack; Fernanda Press; Ruthy Beer-Weisel; Arnon Wiznitzer; Moshe Mazor; Offer Erez
Journal:  PeerJ       Date:  2013-03-19       Impact factor: 2.984

Review 9.  Thrombophilia and pregnancy.

Authors:  Michael J Kupferminc
Journal:  Reprod Biol Endocrinol       Date:  2003-11-14       Impact factor: 5.211

10.  The role of maternal serumbeta-HCG and PAPP-A levels at gestational weeks 10 to 14 in the prediction of pre-eclampsia.

Authors:  Ozkan Ozdamar; Ismet Gun; Ugur Keskin; Necmettin Kocak; Ercument Mungen
Journal:  Pak J Med Sci       Date:  2014-05       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.